AP-1 proteins help cancer cells rewire genes to survive treatment
A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.
A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.
The largest published prospective evaluation of off-label targeted cancer therapies has shown that more patients could benefit from existing drugs.
Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells.
The growing use of electric bikes and scooters has caused a surge in brain and spine injuries among urban riders and pedestrians, a new study shows.
Healthcare registry data can show early risk patterns for melanoma skin cancer, according to a study from the University of Gothenburg.
At this time of year, many people make an extra effort to establish good exercise routines. We know that exercise is good for our health, but it can still be…
Food calorie labels on menus in cafes and restaurants can be helpful for people with binge eating disorders, even aiding their recovery, finds new research from UCL and King's College…
Though many studies approach the developmental disorder Rett syndrome as a single condition arising from general loss of function in the gene MECP2, a new study by neuroscientists in The…
Adults who reported feeling lonely had a higher risk of developing degenerative heart valve disease, even after accounting for traditional heart disease risk factors and genetics, according to new research…
A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to develop kidney failure, years before clinical disease becomes apparent.